Understanding how obesity and diabetes affect metabolism and behavior in mice
Official title: Core C: Phenotyping Core
Funded at University of Michigan at Ann Arbor · NIH-11017760 · Data updated 2026-11-12
This study is looking at how obesity and diabetes affect mice to help us understand these conditions better, which could lead to new treatments for people dealing with them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | February 1, 2023 |
| Project end | January 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $212,705 |
| NIH project number | 5U2CDK135066-03 |
| Project ID | NIH-11017760 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with obesity or diabetes who may benefit from advancements in treatment strategies.
✕Less likely to help
Patients without obesity or diabetes, or those not involved in related metabolic studies, may not receive direct benefits from this research.
What this research studies
This research focuses on the detailed analysis of metabolic and behavioral responses in mouse models of obesity and diabetes. By utilizing advanced equipment and expert consultation, the project aims to uncover the physiological mechanisms that contribute to these conditions. The Phenotyping Core will conduct various assessments, including glucose homeostasis studies and metabolic rate evaluations, to gain insights into how these diseases affect overall health. This work is essential for developing effective treatments for obesity and diabetes.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for obesity and diabetes in humans.
How similar studies have gone: Previous research has shown success in using similar phenotyping approaches to understand metabolic diseases, indicating a promising avenue for further exploration.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Qi, Nathan R. — University of Michigan at Ann Arbor
- Study coordinator: Qi, Nathan R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.